Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

The Bronchial Tree

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting Inflammation in Bronchiectasis.

Drugs·2026

Same author

Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial.

Annals of the American Thoracic Society·2026

Same author

Goodbye seems to be the hardest word: long-term macrolide withdrawal in bronchiectasis.

ERJ open research·2026

Same author

Clinical practice guideline for long COVID prevention and treatment.

The European respiratory journal·2026

Same author

Ten unanswered questions about dipeptidyl peptidase-1 inhibition in bronchiectasis.

The Lancet. Respiratory medicine·2026

Same author

Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network.

ERJ open research·2026

Same journal

The PERC-Peds rule: a promising step towards structured pulmonary embolism risk assessment in children.

The Lancet. Respiratory medicine·2026

Same journal

Intensive care in global conflicts: brace for impact.

The Lancet. Respiratory medicine·2026

Same journal

PERC-Peds rule for bedside exclusion of pulmonary embolism without radiation in children in the USA (BEEPER): a multicentre, prospective, observational, diagnostic accuracy study.

The Lancet. Respiratory medicine·2026

Same journal

RSV vaccination and immunisation programmes accelerating worldwide.

The Lancet. Respiratory medicine·2026

Same journal

Pulmonary fibrosis in chILD: bridging the gap.

The Lancet. Respiratory medicine·2026

Same journal

Heterogeneity of severe asthma in Europe: a SHARP-er view.

The Lancet. Respiratory medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2025

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Rethinking bronchiectasis as an inflammatory disease.

Merete B Long¹, Sanjay H Chotirmall², Michal Shteinberg³

¹Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.

The Lancet. Respiratory Medicine

|July 6, 2024

Summary

This summary is machine-generated.

Bronchiectasis is primarily a chronic inflammatory disease, not just an infection. Early identification and novel anti-inflammatory treatments are key for better patient outcomes.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

Related Experiment Videos

Last Updated: Jun 21, 2025

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

Area of Science:

Pulmonology
Immunology
Pathophysiology

Background:

Bronchiectasis pathogenesis involves infection, impaired mucociliary clearance, inflammation, and lung damage.
Current treatments focus on infection control and mucus clearance, with limited success for long-term antibiotics.
This suggests a need to reconsider bronchiectasis solely as an infective disorder.

Purpose of the Study:

To argue that bronchiectasis is fundamentally a chronic inflammatory condition.
To introduce a novel concept of disease activity for bronchiectasis.
To highlight implications for clinical practice and future research.

Main Methods:

Review of current understanding of bronchiectasis.
Analogy drawn from asthma treatment paradigm shifts.
Discussion of emerging anti-inflammatory therapeutic strategies.

Main Results:

Evidence suggests inflammation is a primary driver in bronchiectasis.
A new conceptual framework for disease activity is proposed.
Potential for novel anti-inflammatory agents to revolutionize care.

Conclusions:

Bronchiectasis should be viewed as a chronic inflammatory disease.
Early identification of at-risk individuals is crucial.
Novel anti-inflammatory treatments offer promising therapeutic avenues.